Literature DB >> 18796596

TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.

C C Weihl1, P Temiz, S E Miller, G Watts, C Smith, M Forman, P I Hanson, V Kimonis, A Pestronk.   

Abstract

TAR DNA binding protein-43 (TDP-43) is found in ubiquitinated inclusions (UBIs) in some frontotemporal dementias (FTD-U). One form of FTD-U, due to mutations in the valosin containing protein (VCP) gene, occurs with an inclusion body myopathy (IBMPFD). Since IBMPFD brain has TDP-43 in UBIs, we looked for TDP-43 inclusions in IBMPFD muscle. In normal muscle, TDP-43 is present in nuclei. In IBMPFD muscle, TDP-43 is additionally present as large inclusions within UBIs in muscle cytoplasm. TDP-43 inclusions were also found in 78% of sporadic inclusion body myositis (sIBM) muscles. In IBMPFD and sIBM muscle, TDP-43 migrated with an additional band on immunoblot similar to that reported in FTD-U brains. This study adds sIBM and hereditary inclusion body myopathies to the growing list of TDP-43 positive inclusion diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796596      PMCID: PMC2586594          DOI: 10.1136/jnnp.2007.131334

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis.

Authors:  M F van der Meulen; J E Hoogendijk; K G Moons; H Veldman; U A Badrising; J H Wokke
Journal:  Neuromuscul Disord       Date:  2001-07       Impact factor: 4.296

Review 2.  Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.

Authors:  Marinos C Dalakas
Journal:  Nat Clin Pract Neurol       Date:  2006-08

Review 3.  Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Authors:  Valerie Askanas; W King Engel
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

4.  TDP-43 in amyotrophic lateral sclerosis: pathophysiology or patho-babel?

Authors:  Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

5.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Authors:  Mark S Forman; Ian R Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David A Drachman; Bharati S Jhaveri; Jason H Karlawish; Alan Pestronk; Thomas W Smith; Pang-Hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

7.  Pathological consequences of VCP mutations on human striated muscle.

Authors:  Christian U Hübbers; Christoph S Clemen; Kristina Kesper; Annett Böddrich; Andreas Hofmann; Outi Kämäräinen; Karen Tolksdorf; Maria Stumpf; Julia Reichelt; Udo Roth; Sabine Krause; Giles Watts; Virginia Kimonis; Mike P Wattjes; Jens Reimann; Dietmar R Thal; Katharina Biermann; Bernd O Evert; Hanns Lochmüller; Erich E Wanker; Benedikt G H Schoser; Angelika A Noegel; Rolf Schröder
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

8.  Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA.

Authors:  A Calado; F M Tomé; B Brais; G A Rouleau; U Kühn; E Wahle; M Carmo-Fonseca
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

9.  beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis.

Authors:  V Askanas; R B Alvarez; W K Engel
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

10.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

View more
  111 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Global gene profiling of VCP-associated inclusion body myopathy.

Authors:  Angèle Nalbandian; Svetlana Ghimbovschi; Shlomit Radom-Aizik; Eric Dec; Jouni Vesa; Barbara Martin; Susan Knoblach; Charles Smith; Eric Hoffman; Virginia E Kimonis
Journal:  Clin Transl Sci       Date:  2012-04-04       Impact factor: 4.689

Review 3.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

Review 4.  Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis.

Authors:  C C Weihl
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 5.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

6.  The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.

Authors:  Carlos J Rodriguez-Ortiz; Julio C Flores; Joanna A Valenzuela; Gema J Rodriguez; Joannee Zumkehr; Diana N Tran; Virginia E Kimonis; Masashi Kitazawa
Journal:  Am J Pathol       Date:  2016-04-20       Impact factor: 4.307

7.  mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.

Authors:  James K Ching; Sarita V Elizabeth; Jeong-Sun Ju; Caleb Lusk; Sara K Pittman; Conrad C Weihl
Journal:  Hum Mol Genet       Date:  2012-12-18       Impact factor: 6.150

8.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

Review 9.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

10.  Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.

Authors:  Jeong-Sun Ju; Rodrigo A Fuentealba; Sara E Miller; Erin Jackson; David Piwnica-Worms; Robert H Baloh; Conrad C Weihl
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.